Suppr超能文献

MDCK(马-达二氏犬肾)细胞:一种用于膜通透性筛选的工具。

MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

作者信息

Irvine J D, Takahashi L, Lockhart K, Cheong J, Tolan J W, Selick H E, Grove J R

机构信息

Affymax Research Institute (a Glaxo Wellcome Company), Santa Clara, California 95051,

出版信息

J Pharm Sci. 1999 Jan;88(1):28-33. doi: 10.1021/js9803205.

Abstract

The goal of this work was to investigate the use of MDCK (Madin-Darby canine kidney) cells as a possible tool for assessing the membrane permeability properties of early drug discovery compounds. Apparent permeability (Papp) values of 55 compounds with known human absorption values were determined using MDCK cell monolayers. For comparison, Papp values of the same compounds were also determined using Caco-2 cells, a well-characterized in vitro model of intestinal drug absorption. Monolayers were grown on 0. 4-microm Transwell-COL membrane culture inserts. MDCK cells were seeded at high density and cultured for 3 days, and Caco-2 cells were cultured under standard conditions for 21 to 25 days. Compounds were tested using 100 microM donor solutions in transport medium (pH 7.4) containing 1% DMSO. The Papp values in MDCK cells correlated well with those in Caco-2 cells (r2 = 0.79). Spearman's rank correlation coefficient for MDCK Papp and human absorption was 0.58 compared with 0.54 for Caco-2 Papp and human absorption. These results indicate that MDCK cells may be a useful tool for rapid membrane permeability screening.

摘要

这项工作的目标是研究使用MDCK(麦迪逊-达比犬肾)细胞作为评估早期药物发现化合物膜通透性特性的一种可能工具。使用MDCK细胞单层测定了55种具有已知人体吸收值的化合物的表观渗透率(Papp)值。为作比较,还使用Caco-2细胞(一种特征明确的肠道药物吸收体外模型)测定了相同化合物的Papp值。单层细胞生长在0.4微米的Transwell-COL膜培养插入物上。MDCK细胞以高密度接种并培养3天,Caco-2细胞在标准条件下培养21至25天。使用含1%二甲基亚砜的转运培养基(pH 7.4)中的100微摩尔供体溶液对化合物进行测试。MDCK细胞中的Papp值与Caco-2细胞中的Papp值相关性良好(r2 = 0.79)。MDCK Papp与人体吸收的斯皮尔曼等级相关系数为0.58,而Caco-2 Papp与人体吸收的斯皮尔曼等级相关系数为0.54。这些结果表明,MDCK细胞可能是一种用于快速膜通透性筛选的有用工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验